17-α hydroxyprogesterone caproate for the prevention of preterm birth

ISSN： 1745-5057

Source： Women's Health, Vol.8, Iss.1, 2012-01, pp. : 21-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of 17 α-hydroxyprogesterone caproate in the prevention of preterm birth

By Meis Paul J

Women's Health, Vol. 2, Iss. 6, 2006-11 ,pp. : 819-824

Future Medicine

Access to resources Recommend Favorite

A randomised controlled double‐blind clinical trial of 17‐hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 122, Iss. 1, 2015-01 ,pp. : 71-79

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacogenomics of 17‐alpha hydroxyprogesterone caproate for recurrent preterm birth: a case–control study

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 125, Iss. 3, 2018-02 ,pp. : 343-350

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is 17α‐hydroxyprogesterone caproate contraindicated in twin gestations?

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 122, Iss. 1, 2015-01 ,pp. : 6-7

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population pharmacokinetics of 17α‐hydroxyprogesterone caproate in singleton gestation

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 82, Iss. 4, 2016-10 ,pp. : 1084-1093

John Wiley & Sons Inc

Access to resources Recommend Favorite